Factors influencing the length of hospital stay during the intensive phase of multidrug-resistant tuberculosis treatment at Amhara regional state hospitals, Ethiopia: a retrospective follow up study
Open Access
- 8 August 2020
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 20 (1) , 1-9
Abstract
Background: The length of hospital stay is the duration of hospitalization, which reflects disease severity and resource utilization indirectly. Generally, tuberculosis is considered an ambulatory disease that could be treated at DOTs clinics; however, admission remains an essential component for patients’ clinical stabilization. Hence, this study aimed to identify factors influencing hospital stay length during the intensive phase of multidrug-resistant tuberculosis treatment. Methods: A retrospective follow-up study was conducted at three hospitals, namely the University of Gondar comprehensive specialized, Borumeda, and Debremarkos referral hospitals from September 2010 to December 2016 (n = 432). Data extracted from hospital admission/discharge logbooks and individual patient medical charts. A binary logistic regression analysis was used to identify factors associated with more extended hospital stays during the intensive phase of multidrug-resistant tuberculosis treatment. Result: Most patients (93.5%) had a pulmonary form of multidrug-resistant tuberculosis and 26.2% had /TB/HIV co-infections. The median length of hospital stays was 62 (interquartile range from 36 to 100) days. The pulmonary form of tuberculosis (Adjusted odds ratio [AOR], 3.47, 95% confidence interval [CI]; 1.31 to 9.16), bedridden functional status (AOR = 2.88, 95%CI; 1.29 to 6.43), and adverse drug effects (AOR = 2.11, 95%CI; 1.35 to 3.30) were factors associated with extended hospital stays. Conclusion: This study revealed that the length of hospital-stay differed significantly between the hospitals. The pulmonary form of tuberculosis decreased functional status at admission and reported adverse drug reactions were determinants of more extended hospital stays. These underscore the importance of early case detection and prompt treatment of adverse drug effects.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort studyBMC Infectious Diseases, 2019
- Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in NigeriaBMJ Global Health, 2016
- Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early dischargeJournal of Antimicrobial Chemotherapy, 2015
- Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South AfricaTropical Medicine & International Health, 2015
- Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in NigeriaPLOS ONE, 2014
- Alcohol, Hospital Discharge, and Socioeconomic Risk Factors for Default from Multidrug Resistant Tuberculosis Treatment in Rural South Africa: A Retrospective Cohort StudyPLOS ONE, 2013
- Nosocomial Transmission of Extensively Drug-Resistant Tuberculosis in a Rural Hospital in South AfricaThe Journal of Infectious Diseases, 2012
- Hospital Readmission in General Medicine Patients: A Prediction ModelJournal of General Internal Medicine, 2009
- Treatment of Multidrug‐Resistant Tuberculosis in San Francisco: An Outpatient‐Based ApproachClinical Infectious Diseases, 2005
- Length of in-hospital stay and its relationship to quality of careQuality and Safety in Health Care, 2002